 EXTON, Pa., July 29, 2021 PRNewswire -- West Pharmaceutical Services, Inc. NYSE: WST today announced its financial results for the second-quarter 2021 and updated full-year 2021 financial guidance. Second-Quarter 2021 Summary comparisons to prior-year period Net sales of 723.6 million grew 37.3; organic sales growth was 30.6. 